Keyphrases
Continuous Infusion
100%
High-dose Cytosine Arabinoside
100%
Childhood Leukemia
100%
Ara-C
75%
Steady-state Plasmas
50%
5-bisphosphate
50%
Rapid Infusion
50%
Loading Dose
50%
Route of Administration
25%
High Dose
25%
Steady State
25%
Ultra-low Dose
25%
Pediatric Patients
25%
Fungal Infection
25%
Deoxycytidine
25%
Consecutive Days
25%
Multiple Organs
25%
Intracellular Level
25%
CSF Concentration
25%
Marrow
25%
Acute Renal Failure
25%
C-level
25%
Treatment-related Mortality
25%
Severe Diarrhea
25%
High-dose Ara-C
25%
Aplasia
25%
Cardiogenic Pulmonary Edema
25%
Partial Remission
25%
Oncolytic
25%
CNS Toxicity
25%
Oncolytic Effect
25%
Dosage Schedule
25%
Relapsed or Refractory Acute Myeloid Leukemia
25%
Transaminase Elevations
25%
C Concentration
25%
Peritonitis
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cytarabine
100%
Childhood Leukemia
100%
Leukemia
16%
Remission
16%
Mycosis
16%
Diarrhea
16%
Acute Kidney Failure
16%
Noncardiogenic Lung Edema
16%
Deoxycytidine Triphosphate
16%
Aplasia
16%
Aminotransferase
16%
Peritonitis
16%